X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21882) 21882
Book Review (5237) 5237
Publication (1782) 1782
Newsletter (533) 533
Book Chapter (149) 149
Book / eBook (67) 67
Conference Proceeding (65) 65
Newspaper Article (43) 43
Dissertation (17) 17
Magazine Article (14) 14
Paper (4) 4
Reference (3) 3
Trade Publication Article (3) 3
Transcript (3) 3
Web Resource (2) 2
Data Set (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (19433) 19433
humans (19257) 19257
transplantation (11749) 11749
female (11044) 11044
male (11039) 11039
hematology (10685) 10685
adult (9185) 9185
hematopoietic stem cell transplantation - adverse effects (9079) 9079
middle aged (8457) 8457
hematopoietic stem cells (8103) 8103
oncology (6978) 6978
stem cells (6285) 6285
immunology (6009) 6009
hematopoietic stem cell transplantation (5905) 5905
adolescent (5356) 5356
bone-marrow-transplantation (5103) 5103
treatment outcome (4295) 4295
aged (4266) 4266
transplantation, homologous (4143) 4143
child (3837) 3837
hematopoietic stem cell transplantation - methods (3451) 3451
retrospective studies (3256) 3256
risk factors (3218) 3218
young adult (3081) 3081
health aspects (3016) 3016
cancer (2877) 2877
care and treatment (2749) 2749
animals (2724) 2724
chemotherapy (2710) 2710
versus-host-disease (2643) 2643
child, preschool (2638) 2638
research (2552) 2552
stem-cell transplantation (2444) 2444
leukemia (2421) 2421
stem cell transplantation (2238) 2238
bone marrow (2150) 2150
transplantation, autologous (2146) 2146
graft vs host disease - etiology (2120) 2120
analysis (2024) 2024
therapy (2013) 2013
hematology, oncology and palliative medicine (1957) 1957
transplantation conditioning - methods (1853) 1853
prognosis (1817) 1817
bone-marrow transplantation (1794) 1794
antineoplastic combined chemotherapy protocols - therapeutic use (1751) 1751
infant (1730) 1730
children (1671) 1671
abridged index medicus (1577) 1577
mortality (1540) 1540
survival analysis (1532) 1532
combined modality therapy (1486) 1486
transplants & implants (1462) 1462
mice (1448) 1448
recurrence (1418) 1418
recipients (1401) 1401
acute myeloid-leukemia (1394) 1394
article (1387) 1387
follow-up studies (1369) 1369
hematologic neoplasms - therapy (1364) 1364
graft vs host disease - prevention & control (1350) 1350
medicine & public health (1350) 1350
pediatrics (1342) 1342
bone marrow transplantation (1329) 1329
diagnosis (1317) 1317
time factors (1298) 1298
disease (1297) 1297
complications and side effects (1295) 1295
disease-free survival (1292) 1292
colony-stimulating factor (1291) 1291
transplantation conditioning - adverse effects (1270) 1270
blood (1265) 1265
survival (1228) 1228
survival rate (1219) 1219
antineoplastic combined chemotherapy protocols - adverse effects (1212) 1212
patient outcomes (1169) 1169
prospective studies (1154) 1154
transplantation conditioning (1130) 1130
medicine, research & experimental (1093) 1093
incidence (1069) 1069
bone-marrow (1052) 1052
hemopoiesis (1045) 1045
transplantation, homologous - adverse effects (1041) 1041
acute disease (1007) 1007
hematopoietic stem cell transplantation - mortality (968) 968
medical research (963) 963
risk (947) 947
high-dose chemotherapy (938) 938
graft vs host disease - immunology (915) 915
cyclophosphamide (913) 913
leukemia, myeloid, acute - therapy (904) 904
risk-factors (899) 899
progenitor cells (889) 889
remission induction (886) 886
immunotherapy (885) 885
t cells (882) 882
usage (879) 879
infectious diseases (874) 874
patients (872) 872
immunosuppressive agents - therapeutic use (871) 871
multiple myeloma - therapy (860) 860
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (42) 42
Online Resources - Online (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Markham Stouffville Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21739) 21739
Chinese (286) 286
Japanese (186) 186
German (111) 111
French (103) 103
Spanish (95) 95
Russian (34) 34
Polish (33) 33
Czech (24) 24
Dutch (12) 12
Italian (11) 11
Swedish (9) 9
Croatian (6) 6
Korean (6) 6
Norwegian (6) 6
Finnish (5) 5
Hungarian (5) 5
Portuguese (5) 5
Slovak (4) 4
Danish (2) 2
Bosnian (1) 1
Hebrew (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Hematology, ISSN 0361-8609, 01/2018, Volume 93, Issue 1, pp. 31 - 39
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 07/2015, Volume 125, Issue 7, pp. 2677 - 2689
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2011, Volume 155, Issue 3, pp. 318 - 327
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9790, pp. 498 - 506
Summary Background Non-randomised studies of haemopoietic stem-cell transplantation (HSCT) in systemic sclerosis have shown improvements in lung function and... 
Internal Medicine | MORTALITY | MEDICINE, GENERAL & INTERNAL | MULTICENTER | RESOLUTION COMPUTED-TOMOGRAPHY | METAANALYSIS | I-II | AUTOIMMUNE-DISEASES | TERM-FOLLOW-UP | SCLERODERMA LUNG-DISEASE | MARROW TRANSPLANTATION | BLOOD | Cyclophosphamide - administration & dosage | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Scleroderma, Systemic - pathology | Male | Tomography, X-Ray Computed | Transplantation, Autologous | Lung - diagnostic imaging | Cyclophosphamide - therapeutic use | Early Termination of Clinical Trials | Scleroderma, Systemic - physiopathology | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Immunosuppressive Agents - administration & dosage | Skin - pathology | Severity of Illness Index | Lung - pathology | Drug Administration Schedule | Chicago | Scleroderma, Systemic - surgery | Total Lung Capacity | Treatment Outcome | Lung - physiopathology | Disease Progression | Vital Capacity | Aged | Hematopoietic Stem Cell Transplantation - methods | Infusions, Intravenous | Skin - physiopathology | Therapeutic Equipoise | Transplantation Conditioning | Scleroderma, Systemic - drug therapy | Care and treatment | Cyclophosphamide | Systemic scleroderma | Scleroderma (Disease) | Transplantation | Research | Health aspects | Hematopoietic stem cells | Patient outcomes | Stem cells | Practice | Comparative analysis | Medical research | Blood products | Transplants & implants | Pulmonary arteries | Mortality | Skin | Autoimmune diseases | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Infection - chemically induced | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 12/2013, Volume 122, Issue 26, pp. 4279 - 4286
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 4, pp. 518 - 525
Abstract We recently observed that dysregulation of the complement system may be involved in the pathogenesis of hematopoietic stem cell... 
Hematology, Oncology and Palliative Medicine | Hematopoietic stem cell transplant | Eculizumab | Thrombotic microangiopathy | Eculizumab pharmacokinetics | CH50 | DIAGNOSIS | LONG-TERM SURVIVORS | COMPLEMENT | HEMOLYTIC-UREMIC SYNDROME | IMMUNOLOGY | TRANSPLANTATION | GLOMERULAR-FILTRATION-RATE | Hematopoietic stem cell | CYSTATIN-C | transplant | Eculizumab pharrnacokinetics | CHRONIC KIDNEY-DISEASE | HYPERTENSION | HEMATOLOGY | CHSO | Hematologic Neoplasms - therapy | Severity of Illness Index | Complement Hemolytic Activity Assay | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Hematologic Neoplasms - mortality | Humans | Child, Preschool | Complement Membrane Attack Complex - antagonists & inhibitors | Thrombotic Microangiopathies - mortality | Transplantation, Autologous | Hematologic Neoplasms - pathology | Transplantation, Homologous | Drug Dosage Calculations | Complement Inactivating Agents - therapeutic use | Hematopoietic Stem Cell Transplantation - adverse effects | Survival Analysis | Hematologic Neoplasms - immunology | Thrombotic Microangiopathies - etiology | Drug Monitoring | Child | Thrombotic Microangiopathies - immunology | Thrombotic Microangiopathies - drug therapy | Hypertension | Enzymes | Mortality | Stem cells | Transplantation | Children | Health aspects | Hematopoietic stem cells | Index Medicus
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2010, Volume 16, Issue 6, pp. 838 - 847
Recent studies have suggested that coinfusion of mesenchymal stem cells (MSCs) the day of hematopoietic cell transplantation (HCT) might promote engraftment... 
Hematology, Oncology and Palliative Medicine | Graft-versus-host disease | Nonmyeloablative | Graft-versus-tumor effects | Hematopoietic cell transplantation | HLA-mismatched | Mesenchymal stem cells | TOTAL-BODY IRRADIATION | DENDRITIC CELLS | DONOR | HEMATOLOGIC MALIGNANCY PATIENTS | PHASE-II | ACUTE MYELOID-LEUKEMIA | IMMUNOLOGY | TRANSPLANTATION | SUSTAINED REMISSIONS | HEMATOLOGY | MYCOPHENOLATE-MOFETIL | T-CELLS | PREDICTIVE FACTORS | Peripheral Blood Stem Cell Transplantation - adverse effects | Peripheral Blood Stem Cell Transplantation - methods | Humans | Middle Aged | Male | Mesenchymal Stem Cell Transplantation - adverse effects | Transplantation, Homologous | Mesenchymal Stromal Cells - immunology | Young Adult | Mesenchymal Stromal Cells - cytology | Adult | Female | Transplantation Conditioning - methods | Child | Graft vs Host Disease - diagnosis | HLA Antigens - immunology | Mesenchymal Stromal Cells - metabolism | Graft vs Tumor Effect | Treatment Outcome | Histocompatibility - immunology | Disease Progression | Hematologic Neoplasms - surgery | Mesenchymal Stem Cell Transplantation - methods | Disease-Free Survival | Pilot Projects | Transplantation Chimera - blood | Adolescent | Survival Analysis | Graft Rejection | Graft vs Host Disease - prevention & control | Aged | Cell research | Transplantation | Hematopoietic stem cells | Stem cells | Index Medicus
Journal Article